BCL2 and Fulminant hepatitis: When applying mRNA encoding Bcl-2 in a mouse model of fulminant hepatitis, the number of apoptotic liver cells showed a significant decrease compared to the saline control (Fig. 4), while pDNA encoding Bcl-2 induced only a minimal therapeutic effect to prevent apoptosis.